Du, R., Shen, W., Liu, Y., Gao, W., Zhou, W., Li, J., . . . Luo, Y. (2019). TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness. Signal Transduct Target Ther.
Παραπομπή Chicago StyleDu, Renle, et al. "TGIF2 Promotes the Progression of Lung Adenocarcinoma By Bridging EGFR/RAS/ERK Signaling to Cancer Cell Stemness." Signal Transduct Target Ther 2019.
Παραπομπή MLADu, Renle, et al. "TGIF2 Promotes the Progression of Lung Adenocarcinoma By Bridging EGFR/RAS/ERK Signaling to Cancer Cell Stemness." Signal Transduct Target Ther 2019.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.